Integra LifeSciences Appoints Deborah Leonetti as President of Integra Surgical
PLAINSBORO, N.J., May 12, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced the promotion of Deborah Leonetti to President of Integra Surgical, which is part of Integra's Medical Instrument business.
"Debbie will be a definite asset to the Integra instrument business," said Bob Perrett, President of Integra Medical Instrument Group. "She has contributed significantly to Integra's growth throughout her 12 years with the company, most recently as Chief Marketing Officer, where she led the company's efforts in global marketing. Her experience encompasses customer service, private label sales and international sales. Debbie has also had relevant experience as a clinical nursing supervisor and in endoscopic sales and marketing. Debbie has consistently delivered superior business results and I'm confident she will do the same in her new role."
The Integra Surgical business includes Jarit(R) Surgical Instruments, Luxtec(R) illumination products, Padgett(TM) instruments, R&B-Redmond(TM) specialty instruments, and Omni-Tract(R) surgical retraction products.
Integra Surgical's primary product categories are:
-- Reusable hand held instruments -- scissors, clamps, dissectors,
curettes, rongeurs, and many others
-- Endoscopy instruments
-- Table mounted retractor systems
-- Sterilization containers -- containers, baskets, accessories
-- Illumination systems -- headlamps, light sources, cables,
loupes, cameras
-- Distributed products
-- CIMS(R) services -- Custom Inventory Management Services
Software
"I am pleased to take the helm of Integra Surgical and look forward to working with a team of seasoned professionals to continue growing the business and supporting our customers," said Ms. Leonetti.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of clinically relevant, innovative, and cost-effective surgical implants and medical instruments. Integra's products, used primarily in neurosurgery, orthopedics and general surgery, are used to treat millions of patients every year. The company's headquarters are in Plainsboro, New Jersey, and it has research and manufacturing facilities throughout the world. For more information visit www.Integra-LS.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in section IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
IART - G
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Integra LifeSciences Holdings Corp.
Integra LifeSciences Holdings Corporation
Gianna Sabella, Director of Corporate Communications
(609) 936-2389
gsabella@integra-LS.com
(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
News Provided by COMTEX